For its fourth quarter of 2024, CRISPR booked revenue of just under $36 million. That was well under the more than $201 million the company earned in the same period of 2023. On the bottom line, ...

KAMPALA - Dr Matthias Magoola says the US Patent and Trademark Office (USPTO) has granted a patent for his invention of the first treatment of cancer using a novel composition of a guided Ribonucleic ...

In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will recover. That isn't the case for many companies that have lagged broader ...

BASF SE, Bayer AG, Syngenta Group, UPL, Corteva, and FMC Corporation Lead the Market Agricultural Microbials Market ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...

Thinkhat attends the Precision Medicine World Conference (PMWC) and unveils the first of its AI-driven healthcare and life science (HLS) p ...

The innovation, he says, could transform the way scientists measure and address genomic breaks in gene-editing systems.

Cutting-edge editing techniques are accelerating efforts to create high-yield, resilient varieties of major agricultural products.

This rise has brought with it a wave of innovation, and nowhere is this more apparent than in the growing number of patent applications for stablecoin technologies. From algorithmic stabilization ...

Credit: Piotr Swat/Shutterstock. Intellia Therapeutics has dosed the first subject in a randomised, placebo-controlled global Phase III trial of its investigational CRISPR-based therapy, NTLA-2002, to ...